WITHDRAWN: The Sub-chronic Administration of Echium Oil Attenuates the Seizure Threshold and Improves Antioxidant Activity in Pentylenetetrazol- induced Seizure Model of Mice

Q3 Pharmacology, Toxicology and Pharmaceutics Current drug discovery technologies Pub Date : 2023-04-18 DOI:10.2174/1570163820666230418114512
Hakimeh Gavzan, Atefeh Araghi, Ramazan Behzadi
{"title":"WITHDRAWN: The Sub-chronic Administration of Echium Oil Attenuates the Seizure Threshold and Improves Antioxidant Activity in Pentylenetetrazol- induced Seizure Model of Mice","authors":"Hakimeh Gavzan,&nbsp;Atefeh Araghi,&nbsp;Ramazan Behzadi","doi":"10.2174/1570163820666230418114512","DOIUrl":null,"url":null,"abstract":"<p><p>The article has been withdrawn at the request of the Corresponding author.</p><p><p>Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.</p><p><p>The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php</p><p><strong>Bentham science disclaimer: </strong>It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously\nsubmitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere\nmust be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting\nthe article for publication the authors agree that the publishers have the legal right to take appropriate action against the\nauthors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright\nof their article is transferred to the publishers if and when the article is accepted for publication.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug discovery technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1570163820666230418114512","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The article has been withdrawn at the request of the Corresponding author.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php

Bentham science disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
摘要:亚慢性给药ececium Oil可降低戊四氮唑诱导的小鼠癫痫发作阈值并提高抗氧化活性
应通讯作者的要求,这篇文章已被撤回。边沁科学为由此造成的不便向本刊读者道歉。边沁编辑政策的文章撤回可以在https://benthamscience.com/editorial-policies-main.phpBentham科学免责声明:这是一个出版的条件,提交给本期刊的手稿尚未发表,不会同时提交或发表在其他地方。此外,任何已在其他地方发表的数据、插图、结构或表格都必须报告,并且必须获得版权许可才能复制。抄袭是严格禁止的,通过提交文章发表,作者同意出版商有法律权利对作者采取适当的行动,如果发现抄袭或捏造信息。通过提交手稿,作者同意如果文章被接受出版,其文章的版权将转移给出版商。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current drug discovery technologies
Current drug discovery technologies Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
3.70
自引率
0.00%
发文量
48
期刊介绍: Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.
期刊最新文献
Harnessing the Therapeutic Potential of Dillenia indica: An Overview of Recent Dosage Form Developments. New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and In silico Studies. Nanoencapsulation of Ruthenium Complex Ru(ThySMet): A Strategy to Improve Selective Cytotoxicity against Breast Tumor Cells in 2D and 3D Culture Models. CBD: A Potential Lead against Hair Loss, Alopecia, and its Potential Mechanisms. The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1